These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 738324)

  • 21. The reversible binding of vinblastine to platelets: implications for therapy.
    Kelton JG; McDonald JW; Barr RM; Walker I; Nicholson W; Neame PB; Hamid C; Wong TY; Hirsh J
    Blood; 1981 Mar; 57(3):431-8. PubMed ID: 7459430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid-phase extraction of vinblastine and vincristine from plasma and urine: variable drug recoveries due to non-reproducible column packings.
    Vendrig DE; Holthuis JJ; Erdélyi-Tóth V; Hulshoff A
    J Chromatogr; 1987 Feb; 414(1):91-100. PubMed ID: 3571394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.
    Ushigome F; Takanaga H; Matsuo H; Yanai S; Tsukimori K; Nakano H; Uchiumi T; Nakamura T; Kuwano M; Ohtani H; Sawada Y
    Eur J Pharmacol; 2000 Nov; 408(1):1-10. PubMed ID: 11070177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine.
    Zhou XJ; Martin M; Placidi M; Cano JP; Rahmani R
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):323-32. PubMed ID: 2088769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).
    Rahmani R; Martin M; Barbet J; Cano JP
    Cancer Res; 1984 Dec; 44(12 Pt 1):5609-13. PubMed ID: 6498821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of colchicine-3H to vinblastine- and vincristine-induced crystals in mammalian tissue culture cells.
    Krishan A; Hsu D
    J Cell Biol; 1971 Feb; 48(2):407-10. PubMed ID: 4101525
    [No Abstract]   [Full Text] [Related]  

  • 27. Increase of cyclic adenosine 3':5'-monophosphate concentration in transplantable lymphoma cells by vinca alkaloids.
    Kotani M; Koizumi Y; Yamada T; Kawasaki A; Akabane T
    Cancer Res; 1978 Sep; 38(9):3094-9. PubMed ID: 209896
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy.
    Schmidt MS; Huang R; Classon RJ; Murry DJ
    J Pharm Biomed Anal; 2006 May; 41(2):540-3. PubMed ID: 16414232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells.
    Van Belle SJ; De Smet MC; De Mey JE; Storme GA
    Anticancer Res; 1991; 11(1):465-71. PubMed ID: 2018383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia.
    Inaba M; Sakurai Y
    Cancer Lett; 1979 Dec; 8(2):111-5. PubMed ID: 555868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of vinblastine-loaded platelets utilized in the treatment of platelet-phagocytizing tumors.
    Panasci LC; Comis R; Ginsberg S; Rudolph A; Theodorakis M; Klag M; Fitzpatrick A; Rubert M; Cable R; Davey F
    Cancer Treat Rep; 1980; 64(12):1227-33. PubMed ID: 7193519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of [3H]-vincristine in man.
    Bender RA; Castle MC; Margileth DA; Oliverio VT
    Clin Pharmacol Ther; 1977 Oct; 22(4):430-5. PubMed ID: 902455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
    Al-Ahmad A; Kümmerer K
    Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vinblastine and vincristine on platelets and leucocytes.
    Chandorkar AG
    Indian J Physiol Pharmacol; 1973; 17(2):105-10. PubMed ID: 4766704
    [No Abstract]   [Full Text] [Related]  

  • 35. Difference in effects of vinblastine and vincristine on the dog platelet aggregation.
    Takano S
    Tohoku J Exp Med; 1981 Sep; 135(1):79-85. PubMed ID: 7324052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Endophytic Fungus, Talaromyces radicus, Isolated from Catharanthus roseus, Produces Vincristine and Vinblastine, Which Induce Apoptotic Cell Death.
    Palem PP; Kuriakose GC; Jayabaskaran C
    PLoS One; 2015; 10(12):e0144476. PubMed ID: 26697875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of vinblastine in rat blood plasma and tumour tissue determined by a biological method using flow cytofluorimetry.
    Kipp JB; Barendsen GW
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):867-73. PubMed ID: 7198977
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of vinca alkaloids in human plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Ramírez J; Ogan K; Ratain MJ
    Cancer Chemother Pharmacol; 1997; 39(4):286-90. PubMed ID: 9025768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study.
    Lengsfeld AM; Dietrich J; Schultze-Maurer B
    Cancer Res; 1982 Sep; 42(9):3798-805. PubMed ID: 7105045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.